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To the Editor: Middle East 
respiratory syndrome coronavirus 
(MERS-CoV) was first diagnosed in 
humans in 2012. Human-to-human 
transmission of MERS-CoV has been 
limited, and the transmission route is 
still unclear. On the basis of epide-
miologic studies, involvement of an 
animal host has been suggested (1). 
Dromedary camels have been identi-
fied as a possible intermediate host 
on the basis of MERS-CoV antibod-
ies and detection of MERS-CoV viral 
RNA in respiratory swab samples (1–
3). Furthermore, MERS-CoV genome 
sequences obtained from dromedary 
camels clustered with MERS-CoV 
sequences obtained from humans 
linked to the same farm (2). Nonethe-
less, most persons with MERS-CoV 
did not report any direct contact with 
dromedary camels; therefore, how 
MERS-CoV zoonotic transmission 
occurs is unclear. MERS-CoV repli-
cates in cell lines originating from a 
wide variety of different hosts, which 
suggests the potential for a broader 
reservoir species range then current-
ly recognized (4). However, unlike 
in dromedary camels, no serologic 
evidence pointing toward MERS-
CoV infection has been found in 
goats, sheep, and cows (1).
Contamination of dairy products 
has been associated with transmis-
sion of bacteria and viruses. Shedding 
of infectious tick-borne encephalitis 
virus in milk was detected after ex-
perimental infection of goats, and the 
consumption of raw milk has been 
associated with tick-borne encephali-
tis virus clusters (5). Similarly, cattle 
can be infected with foot-and-mouth 
disease through consumption of raw 
contaminated milk (6).
Here, we investigate the stability 
of MERS-CoV in dromedary camel 
milk, goat milk, and cow milk at dif-
ferent temperatures. MERS-CoV 
strain Jordan-N3/2012 was diluted in 
unpasteurized milk or nonsupplement-
ed Dulbecco modified Eagle medium 
(DMEM, GIBCO, Grand Island, NY, 
USA) to a final median 50% tissue 
culture infectious dose of 105.5/mL. 
We placed 1-mL aliquots in screw-cap 
tubes (Sarstedt, Nümbrecht, Germa-
ny) at either 4°C or 22°C and stored 
them at –80°C at 0, 8, 24, 48, and 72 
hours post dilution (hpd) in quintu-
plicate. Infectious virus titers were 
determined by endpoint titration on 
Vero E6 cells in triplicate (7). When 
MERS-CoV was stored at 4°C, the 
geometric mean of infectious virus 
titers decreased over 72 hours; we 
found they decreased 37% (95% CI 
0%–62%) in dromedary camel milk, 
64% (95% CI 26%–82%) in goat 
milk, 56% (95% CI 0%–92%) in cow 
milk, and 80% (95% CI 70%–86%) in 
DMEM. At 0–72 hpd, virus titers de-
creased significantly only in goat milk 
(p = 0.0139, 1-tailed paired t test) and 
DMEM (p = 0.0311) but not in drom-
edary camel milk (p = 0.1414) or cow 
milk (p = 0.2895). Samples stored at 
22°C showed a greater loss of infec-
tivity than did samples stored at 4°C. 
Infectious virus titers decreased to 
<15% when samples were stored at 
22°C for 48 hours (loss of 88% [95% 
CI 67%–96%] for dromedary camel 
milk, 99% [95% CI 98.6%–99.8%] for 
goat milk, 98% [95% CI 95%–99%] 
for cow milk, and 97% [95% CI 87%–
99%] for DMEM). This decrease was 
significant by student 1-tailed paired 
t test analysis comparing t = 0 and t 
= 48 hpd (p<0.05). However, despite 
the reduction in virus titer, viable vi-
rus could still be recovered after 48 
hours. Pasteurization of raw milk can 
prevent foodborne disease outbreaks 
caused by a variety of pathogens. We 
heat-treated dromedary camel, cow, 
goat milk, and DMEM samples for 30 
min at 63°C, after which no infectious 
virus could be recovered (Figure).
CoV survival has been studied in 
phosphate-buffered saline and minimal 










human coronaviruses–229E and 
-OC43 and severe acute respiratory 
syndrome–CoV were able to survive 
in suspension at room temperature for 
several days (8,9). Moreover, severe 
acute respiratory syndrome–CoV was 
completely inactivated after heat treat-
ment at 60°C for 30 min (9).
Human-to-human transmission 
of MERS-CoV is inefficient, and the 
transmission route has not yet been 
revealed. The predominant detection 
of MERS-CoV by quantitative PCR in 
nasal swab samples suggests the virus 
causes upper respiratory tract infec-
tion in dromedary camels (3). Which 
route or combination of routes is re-
sponsible for its zoonotic transmission 
is unclear, and foodborne transmission 
should not be excluded. Residents of 
the Arabian Peninsula commonly 
drink unpasteurized milk. Our results 
show that MERS-CoV, when intro-
duced into milk, can survive for pro-
longed periods. Further study is need-
ed to determine whether MERS-CoV 
is excreted into the milk of infected 
dromedary camels and, if so, whether 
handling or consuming contaminated 
milk is associated with MERS-CoV 
infection. Recently Nipah virus was 
transmitted experimentally by drink-
ing , which resulted in respiratory tract 
rather than intestinal tract infection 
(10). A similar transmission mecha-
nism for MERS-CoV could result in 
contamination of the oral cavity and 
subsequent infection of the lower re-
spiratory tract. Pasteurization of milk 
can prevent foodborne transmission 
(9). We showed that heat treatment de-
creased infectious MERS-CoV below 
the detection limit of our titration as-
say, and this might function as a rela-
tively easy and cost-effective measure 
to prevent transmission.
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To the Editor: Carbapenem 
antimicrobial drugs are the line of 
defense against multidrug-resistant 
gram-negative bacterial infections. 
The global emergence of carbapene-
mase-producing organisms is a pub-
lic health emergency because these 
enzymes confer resistance to nearly 
all β-lactam drugs and are often as-
sociated with multidrug or pandrug 
resistance (1). Alarmingly, reports 
of carbapenemase-producing organ-
isms from environmental and animal 
sources, including food animals, are 
increasing (1). Recently, clinical iso-
lates of Salmonella enterica serotype 
Kentucky that produce VIM-2 and 
OXA-48 were reportedly isolated 
from patients in France with a travel 
history to Africa and the Middle East, 
suggesting foodborne transmission of 
carbapenemase producers (2).
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